6月3日，截至港股收盘，恒生指数上涨1.53%，报23512.49点。优趣汇控股（02177.HK）收报3.55港元/ 股，上涨24.13%，成交量71.4万股，成交额223.09万港元，振幅25.17%。 最近一个月来，优趣汇控股累计涨幅22.75%，今年来累计涨幅104.29%，跑赢恒生指数15.44%的涨幅。 其上市主体,优趣汇控股有限公司(股票代码:02177.HK)于2021年7月12日正式登陆港交所主板,作为中国 电商细分领域的龙头企业,优趣汇从此迈入新的征程。 （以上内容为金融界基于公开消息，由程序或算法智能生成，不作为投资建议或交易依据。） 财务数据显示，截至2024年12月31日，优趣汇控股实现营业总收入13.48亿元，同比减少22.32%；归母 净利润3789.2万元，同比增长308%；毛利率30.01%，资产负债率39.45%。 来源：金融界 机构评级方面，目前暂无机构对该股做出投资评级建议。 行业估值方面，专业零售行业市盈率（TTM）平均值为4.76倍，行业中值-0.27倍。优趣汇控股市盈率 11.6倍，行业排名第15位；其他宝光实业（00084.HK）为0.18倍、陈唱国际（0069 ...

1957年，管理学大师伊戈尔·安索夫在《哈佛商业评论》中提出了著名的"安索夫矩阵"概念。这个矩阵 透过两个维度（现有产品/新产品、现有市场/新市场），把企业战略决策分为了四个象限。安索夫认 为，如果一家企业一直以"守成"的心态待在现有市场，并且不对产品进行积极的研发与创新，那么这个 企业很容易因为触及瓶颈而止步不前，甚至可能会随着原有市场的竞争烈度加剧而失去竞争力。 安索夫的论断表明，一味保守经营对于企业来说算不上好事，只有在保持稳健的基础上积极向新市场、 新产品发力，企业才有可能蹚出一条可持续发展之路。 智通财经认为，安索夫的理论非常适用于如今的电商代运营行业。随着综合电商渗透逐步见顶，加之消 费仍处于恢复期，国内电商环境已更趋复杂。存量市场里，电商代运营也已经来到了需要求变的时刻 了。 面对新环境、新变化，业内领先的品牌电商运营服务商优趣汇控股（02177）主动向外探出了关键的一 步。去年下半年，优趣汇推出了包含麦角硫因活性成分的加拿大抗衰老健康食品品牌Vanpearl；同时， 为了尽快在新市场中站稳脚跟，优趣汇还专门聘请了行业技术大咖Barry Halliwell教授担任公司的首席 科学家暨首席健康科技 ...

机构评级方面，目前暂无机构对该股做出投资评级建议。 5月28日，截至港股收盘，恒生指数下跌0.53%，报23258.31点。优趣汇控股（02177.HK）收报2.54港 元/股，上涨14.41%，成交量114.36万股，成交额282.63万港元，振幅13.06%。 最近一个月来，优趣汇控股累计跌幅9.02%，今年来累计涨幅58.57%，跑赢恒生指数16.56%的涨幅。 财务数据显示，截至2024年12月31日，优趣汇控股实现营业总收入13.48亿元，同比减少22.32%；归母 净利润3789.2万元，同比增长308%；毛利率30.01%，资产负债率39.45%。 行业估值方面，专业零售行业市盈率（TTM）平均值为4.69倍，行业中值-0.26倍。优趣汇控股市盈率9 倍，行业排名第13位；其他宝光实业（00084.HK）为0.18倍、陈唱国际（00693.HK）为4.75倍、宝胜国 际（03813.HK）为5.29倍、ASIA COMM HOLD（00104.HK）为5.3倍、周生生（00116.HK）为6.41 倍。 资料显示，优趣汇控股有限公司,是中国领先的品牌电子商务运营服务商,专注于美妆产品、成人个护、 ...

普葆™起源于爱尔兰科克大学实验室，25年专研人体微生态，依托其科研团队在微生物领域积累的深厚专业背景，在菌株鉴定、基因表达分析以及精准筛选 方面得到了业界高度认可。品牌聚焦精准专效益生菌解决方案，所开发的益生菌产品均选自人类肠道中的天然菌株，确保产品的安全性与专效性，有效帮助 消费者解决现代生活所面临的特定健康困扰。旗下爱弗乐（Alforex）双效益生菌产品，是专门针对肠易激综合征（IBS）的解决方案，融合了经过科学验证 的长双歧杆菌35624™和1714™专研菌株，协同发挥作用。研究证实，它能改善肠道环境，在缓解腹痛、腹泻、便秘、胀气等肠道不适症状方面表现出显著 的效果。同时，它对舒压助眠、调节情绪起着积极的作用。 此次战略合作，双方将在多个维度展开深度协作。优趣汇将利用自身在电商平台运营、营销推广、供应链管理等方面的丰富经验，助力普葆™精准触达中国 消费者，提升品牌在中国的市场份额。 智通财经APP获悉，5月22日，优趣汇(02177)与诺和新元旗下的高端原研益生菌品牌普葆™（PrecisionBiotics）在广州举行了隆重的战略合作签约仪式，诺 和新元消费品健康亚太区负责人程锡安先生及优趣汇保健食品事 ...

Financial Performance - In 2024, the company achieved a net profit of RMB 36.5 million, a significant increase of 308.1% year-on-year, marking a turnaround from previous losses [9]. - The overall gross margin for 2024 was 30.0%, an increase of 3.7 percentage points compared to 2023, despite a decrease in revenue scale [11]. - In 2024, the company's total revenue was RMB 1,348.4 million, a decrease of 22.3% compared to the previous year, primarily due to strategic optimization of existing brands and channels, and a decline in consumer confidence in the Chinese market [17]. - Operating profit for 2024 was RMB 27.8 million, a significant improvement from an operating loss of RMB 7.9 million in 2023, primarily due to reduced operating expenses and improved inventory turnover [28]. - The company achieved earnings per share of RMB 0.23 in 2024, compared to a loss per share of RMB 0.11 in 2023 [29]. - The company reported a financial income of RMB 10,410 thousand in 2024, up from RMB 4,802 thousand in 2023 [191]. - The total operating costs decreased to RMB 943,705 thousand in 2024 from RMB 1,279,245 thousand in 2023, contributing to improved profitability [191]. - The company declared dividends amounting to RMB 37,644 thousand in 2024, compared to RMB 18,203 thousand in 2023, reflecting an increase of approximately 106.7% [199]. Revenue and Sales - The sales volume of the Ansu brand's fly bait exceeded 750,000 bottles in 2024, representing a growth of 40% year-on-year [10]. - The sales revenue of adult personal care products decreased by 20.6% year-on-year, while infant personal care products saw a decline of 35.6%, mainly due to market demand reduction and increased competition [21]. - The health product sales revenue decreased by 21.3% year-on-year, impacted by brand events and stock shortages, although a new anti-aging health food brand was successfully launched in the second half of 2024 [21]. - Total revenue for the year ended December 31, 2024, was approximately RMB 1,336,824,000, with B2B sales contributing RMB 649,007,000 and B2C sales contributing RMB 687,817,000 [180]. Inventory and Cash Management - The company’s inventory as of December 31, 2024, was RMB 265.0 million, down 5.2% from RMB 279.6 million in the previous year [11]. - Cash and cash equivalents increased to RMB 438.6 million as of December 31, 2024, up by RMB 100.2 million from RMB 338.4 million in 2023 [30]. - Net cash generated from operating activities was RMB 172.2 million, reflecting improved cash flow management and inventory turnover [31]. Operational Efficiency and Strategy - The company continues to optimize its business structure by terminating low-margin business collaborations to enhance operational efficiency [11]. - The company is focused on leveraging digital tools to improve efficiency across various business segments [11]. - The company plans to strengthen its profitable business scale and profit through the establishment of an AI task force and the integration of AI technologies into its operations [15]. - The group plans to implement a "Efficiency Revolution" in its existing e-commerce operations, focusing on refined operations, cost reduction, and enhanced AI technology application [45]. Market Position and Brand Development - The new product "Morning Day and Night Pants" from the Sofy brand ranked TOP 1 in Tmall's new sanitary napkin product list for the 38th anniversary [10]. - The Kose Cosmeport brand's cleansing oil achieved TOP 1 in Tmall's imported cleansing oil repurchase list during the Double Eleven shopping festival [10]. - The company was recognized as a "Five-Star Operating Service Provider" and "Super V-Partner" by Tmall for its operational capabilities [10]. Corporate Governance and Compliance - The company has established three board committees, including the audit committee, remuneration committee, and nomination committee, to oversee specific areas of governance [128]. - The company is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance corporate value [124]. - The independent auditor's report confirmed that the consolidated financial statements fairly reflect the group's financial position as of December 31, 2024 [177]. - The company has complied with all relevant laws and regulations that significantly impact its business and operations during the reporting period [108]. Employee Relations and Diversity - The group has maintained stable employee relations without significant strikes or labor disputes affecting business activities [40]. - The group is committed to providing competitive compensation packages to retain employees, including salaries, discretionary bonuses, and benefits plans [40]. - As of December 31, 2024, female employees represent approximately 73.7% of the total workforce, including senior management [136]. - The company emphasizes gender diversity at all levels, particularly in the boardroom, and is committed to providing career development opportunities for employees [136]. Future Outlook and Challenges - The external environment for 2025 remains uncertain, with unfavorable factors such as international instability and weak consumer sentiment [44]. - The group is confident in navigating uncertainties in 2025, leveraging its accumulated operational experience and professional expertise [44]. - The company aims to explore overseas business development opportunities in North America and Southeast Asia, leveraging its mature e-commerce operational capabilities [15].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不 負 責，對 其 準 確 性 或 完 整 性 亦 不 發 表 任 何 聲 明，並 明 確 表 示，概 不 對 因 本 公 告 全部或任何部分內容而產生或因倚賴該等內容而引致的任何損失承擔任何責 任。 UNQ HOLDINGS LIMITED 優趣匯控股有限公司 （於 開 曼 群 島 註 冊 成 立 的 有 限 公 司） （股 份 代 號：2177） 截 至2024年12月31日止年度之年度業績公告 財務摘要 收入下滑 • 截 至2024年12月31日止年度的收入為人民幣1,348.4百 萬 元，與 截 至2023 年12月31日止年度相比減少22.3%。 毛利率提升 • 截 至2024年12月31日止年度的毛利率為30.0%，相 較 於 截 至2023年12月31 日止年度的毛利率26.3%，增 加3.7個 百 分 點。 淨利潤實現扭虧為盈 – 2 – • 截 至2024年12月31日止年度的淨利潤為人民幣36.5百 萬 元，與 截 至2023 年12月31日止年度的淨虧損人民幣17.5百 萬 元 相 比，提 升308.1%。 每股基本收益回正 ...

ழி unq 优 趣 汇 控 股 有 限 公 司 UNQ HOLDINGS LIMITED (incorporated in the Cayman Islands with limited liability) ( 於飼曼群島註冊成立的有限公司 ) Stock Code 股份代號：2177 2024 Interim Report 中 期 報 告 | --- | --- | |-------|--------------------------| | | | | | | | 2 | 公司簡介 | | 3 | 公司資料 | | 5 | 財務摘要 | | 6 | 管理層討論與分析 | | 14 | 其他資料 | | 21 | 中期簡明綜合全面收入表 | | 23 | 中期簡明綜合資產負債表 | | 25 | 中期簡明綜合權益變動表 | | 26 | 中期簡明綜合現金流量表 | | 27 | 中期簡明綜合財務資料附註 | 公司簡介 優趣匯控股有限公司（「本公司」或「我們」，連同其附屬公司為「本集團」）是中國領先的品牌電子商務運營服務商，專注 於快速消費品，包括成人個人護理產品、嬰幼兒個人護理產品、美妝產品、健康產品及 ...

Financial Performance - Revenue for the six months ended June 30, 2024, was RMB 613.3 million, a decrease of 32.0% compared to the same period last year[2] - Net profit for the six months ended June 30, 2024, was RMB 23.7 million, an increase of 981.1% compared to RMB 2.2 million in the same period last year[2] - Basic earnings per share for the six months ended June 30, 2024, was RMB 0.15, compared to RMB 0.01 in the same period last year[4] - The total revenue for the six months ended June 30, 2024, was RMB 613,304 thousand, a decrease from RMB 901,925 thousand in the same period of 2023, representing a decline of approximately 32.0%[56] - The gross margin for the first half of 2024 was 30.0%, an increase of 3.2 percentage points from 26.8% in the same period last year, while net profit rose to RMB 23.7 million, a significant increase of 981.1% year-on-year[54] Assets and Liabilities - Total assets as of June 30, 2024, amounted to RMB 1,169.1 million, compared to RMB 1,157.4 million as of December 31, 2023[6] - Current assets totaled RMB 1,042.9 million as of June 30, 2024, slightly up from RMB 1,040.4 million as of December 31, 2023[5] - Total liabilities decreased to RMB 425.7 million as of June 30, 2024, from RMB 430.1 million as of December 31, 2023[6] - The total equity attributable to owners of the company as of June 30, 2024, was RMB 741,054,000, up from RMB 727,258,000 at the beginning of the year[7] Cash Flow - The cash flow from operating activities for the six months ended June 30, 2024, was RMB 88,648,000, a significant increase from RMB 865,000 in the same period of 2023[9] - Cash and cash equivalents increased to RMB 365.4 million as of June 30, 2024, from RMB 338.4 million as of December 31, 2023[5] - The net cash generated from operating activities was RMB 88.6 million, primarily from operating income of RMB 77.7 million and income tax refunds of RMB 5.4 million[63] - The net cash used in investing activities was RMB 8.7 million, mainly for purchasing financial products[64] - The net cash used in financing activities was RMB 52.8 million, primarily due to the group's efforts to reduce the debt ratio, with net loan repayments of RMB 48.6 million[64] Expenses - The company reported a significant reduction in selling and marketing expenses to RMB 135.2 million from RMB 197.9 million in the same period last year[3] - Research and development expenses increased to RMB 2.3 million for the six months ended June 30, 2024, compared to RMB 1.8 million in the same period last year[3] - Cost of goods sold decreased to RMB 429,094 thousand for the six months ended June 30, 2024, down from RMB 660,115 thousand in 2023, reflecting a reduction of approximately 35%[8] - Sales and marketing expenses were reduced to RMB 45,794 thousand, a decrease of about 41% from RMB 77,152 thousand in the previous year[8] Revenue Breakdown - B2B and B2C sales accounted for RMB 271,246 thousand for the six months ended June 30, 2024, down from RMB 416,907 thousand in 2023, representing a decline of 35%[26] - Major customer A contributed RMB 196,072 thousand in revenue for the six months ended June 30, 2024, compared to RMB 331,455 thousand in 2023, reflecting a decrease of 41%[29] - Revenue from Douyin and Pinduoduo accounted for 11.1% of the company's total revenue in the first half of 2024, indicating successful channel expansion efforts[54] - Sales revenue for adult personal care products decreased by 29.5% year-over-year, primarily due to a decline in brand strength and reduced sales through low-margin channels[57] - Sales revenue for infant personal care products dropped by 45.8% year-over-year, influenced by declining birth rates and increased market competition[57] Corporate Governance - The board of directors has established an audit committee, consisting of three independent non-executive directors, to oversee financial reporting and risk management[82] - The company has adhered to the corporate governance code and will continue to review its governance practices to ensure compliance[77] - The company will continue to assess the effectiveness of its corporate governance structure and may consider separating the roles of chairman and CEO in the future[78] - The company is committed to maintaining high standards of corporate governance to protect shareholder interests and enhance corporate value[77] Future Plans - The company plans to continue optimizing its brand and channel structure to enhance operational quality and efficiency moving forward[54] - The group plans to continue advancing its own and co-created brands in health food and skincare, expanding brand influence and sales in the second half of 2024[75] - The company will increase investment in the Douyin platform to drive traffic conversion, user growth, and consumer loyalty[75] Dividends - The company announced an interim dividend of HKD 0.25 per share for the six months ended June 30, 2024, compared to HKD 0.12 for the same period in 2023, totaling approximately HKD 41.5 million[80] - The interim dividend is expected to be paid on September 26, 2024[80] Investment Proceeds - The net proceeds from the listing on July 12, 2021, amounted to approximately HKD 320 million after deducting underwriting fees and estimated expenses[83] - 54.3% of the proceeds (HKD 174 million) is allocated for investment in social media marketing, brand development, and enriching the brand, expected to be utilized by December 31, 2024[83] - 15.7% of the proceeds (HKD 50 million) is designated for enhancing supply chain management and enriching health product brands, with no funds utilized as of the report date[83] - 7.0% of the proceeds (HKD 22 million) is aimed at strengthening technology systems and product types, with HKD 17 million expected to be utilized by December 31, 2024[83] - 13.0% of the proceeds (HKD 42 million) is planned for strategic investments in technology companies and O2O service providers, with full utilization expected by December 31, 2024[83]

Financial Performance - The net loss for 2023 was RMB 17.5 million, representing an 85.0% reduction compared to a net loss of RMB 116.8 million in the previous year[12]. - In 2023, the company's total revenue was RMB 1,735.9 million, a decrease of 27.0% compared to the previous year[22]. - The sales revenue of adult personal care products decreased by 27.7% year-on-year, primarily due to a decline in market competitiveness and the termination of low-margin brand collaborations[28]. - The sales revenue of infant personal care products fell by 28.5% year-on-year, influenced by declining birth rates and intensified market competition[28]. - The sales revenue of beauty products decreased by 37.4% year-on-year, impacted by the termination of low-margin brand collaborations and competition from local brands[28]. - The revenue from service provision decreased by 37.9% year-on-year due to the closure of unprofitable operations[29]. - The operating loss for 2023 was RMB 79 million, significantly improved from a loss of RMB 122.5 million in the previous year, due to reduced marketing expenses by 48.8% and logistics costs by 27.9%[36]. - The gross profit for the group in 2023 was RMB 456.7 million, with a gross margin of 26.3%, an increase of 2.4 percentage points from 2022[33]. - The gross profit margin for 2023 was 26.3%, an increase of 2.4 percentage points from 23.9% in the previous year, attributed to improved product structure and inventory management[30]. Inventory and Cash Management - As of December 31, 2023, the company's inventory was RMB 279.6 million, a decrease of RMB 256.1 million or 47.8% year-on-year[10]. - The net cash generated from operating activities was RMB 143.7 million, down from RMB 260 million in 2022, reflecting stable cash flow management despite inventory control efforts[40]. - The group’s cash and cash equivalents as of December 31, 2023, were RMB 338.4 million, a decrease from RMB 417.6 million at the beginning of the year[38]. - The debt-to-equity ratio improved to -14.6% as of December 31, 2023, compared to 4.5% in 2022, indicating a reduction in borrowings and higher cash reserves[42]. Marketing and Revenue Channels - Revenue from Douyin and Pinduoduo channels increased by 36.8% and 52.2% year-on-year, respectively[16]. - Revenue from Douyin and Pinduoduo increased by 36.8% and 52.2% respectively compared to the previous year, with their contribution to total revenue rising from 5.3% in 2022 to 10.5% in 2023[21]. - The company plans to enhance existing profitable businesses and invest more in emerging channels like Douyin and Pinduoduo to connect brands with consumers effectively[20]. - Increased investment in platforms like Douyin and Pinduoduo will be prioritized, along with establishing a comprehensive influencer matrix[57]. Strategic Initiatives and Partnerships - The company achieved a Guinness World Record by selling 20,097,237 pieces of Sofy sanitary napkins within 24 hours on Tmall Supermarket[14]. - A strategic partnership was established with Shiseido Group to co-create a body care series under the brand "Yiyezi," exploring new market opportunities[17]. - The company expanded its brand portfolio by adding six new brands, including Cocunat and Algotherm, during the reporting period[14]. - The company aims to develop its own brand business in health food and effective skincare products to create a second growth curve[20]. - The company plans to focus on health food and effective skincare products through brand co-creation and incubation of proprietary brands[57]. Governance and Management - The board consists of 3 executive directors, 1 non-executive director, and 3 independent non-executive directors, complying with listing rules regarding independent director appointments[164]. - The company has adopted the 2022 Restricted Share Unit Plan effective from June 22, 2022, aimed at rewarding selected participants for their contributions[118]. - The independent non-executive directors have confirmed their independence during the reporting period[106]. - The company has established appropriate insurance arrangements for directors and senior officers to cover costs and liabilities incurred in the execution of their duties[148]. - The board has established three committees: audit committee, remuneration committee, and nomination committee, each with defined responsibilities[185]. Shareholder Information - Mr. Wang Yong holds 64,392,700 shares, representing approximately 38.82% of the company's equity[114]. - Major shareholder Wisdom Oasis owns 64,392,700 shares, accounting for 38.82% of the equity, while TCI holds 57,264,100 shares, representing 34.52%[116]. - The company did not recommend a final dividend for the year ending December 31, 2023, due to cumulative losses[86]. - The company reported zero distributable reserves as of December 31, 2023, consistent with the previous year[100]. Environmental and Social Responsibility - The company has recognized the importance of environmental protection and is committed to low-carbon development and green operations[154]. - Charitable donations made by the company for the year ending December 31, 2023, totaled RMB 469,379, an increase from RMB 142,896 in 2022[102]. Future Outlook - The external environment for 2024 remains uncertain, with unfavorable factors such as international instability and weak consumer sentiment[56]. - The company aims to enhance existing operations to improve quality and efficiency, laying a solid foundation for future development[57].

Financial Performance - For the year ended December 31, 2023, the revenue was RMB 1,735.9 million, a decrease of 27.0% compared to RMB 2,379.0 million for the year ended December 31, 2022[4] - The net loss for the year ended December 31, 2023, was RMB 17.5 million, a reduction of 85.0% compared to a net loss of RMB 116.8 million for the year ended December 31, 2022[4] - The operating loss for the year ended December 31, 2023, was RMB 7.9 million, compared to an operating loss of RMB 122.5 million for the previous year[5] - The total comprehensive loss for the year ended December 31, 2023, was RMB 17.8 million, compared to RMB 85.7 million for the year ended December 31, 2022[6] - The company reported a basic loss per share of RMB 0.11 for the year ended December 31, 2023, compared to RMB 0.71 for the year ended December 31, 2022[6] Revenue Breakdown - B2B sales contributed RMB 843,128,000 in 2023, down from RMB 1,176,588,000 in 2022, reflecting a decrease of about 28%[21] - B2C sales generated RMB 877,174,000 in 2023, compared to RMB 1,177,313,000 in 2022, marking a decline of approximately 25%[21] - Revenue from Douyin and Pinduoduo for the year ended December 31, 2023, increased by 36.8% and 52.2%, respectively, compared to the same period last year[4] - Sales of adult personal care products decreased by 27.7% year-on-year, primarily due to a decline in market influence and the termination of partnerships with low-margin brands[57] - Sales of infant personal care products fell by 28.5%, impacted by a declining birth rate and increased competition in the domestic market[58] - Revenue from beauty products dropped by 37.4%, influenced by the termination of partnerships with low-margin brands and competition from local brands[59] - Revenue from services decreased by 37.9%, mainly due to the cessation of unprofitable businesses[60] Cost and Expenses - The cost of goods sold for the year was RMB 1,263,651,000, down from RMB 1,782,892,000 in 2022, indicating a reduction of about 29%[25] - The company’s operating expenses for the year were RMB 1,716,717,000, down from RMB 2,489,198,000 in 2022, representing a decrease of about 31%[25] - The group reduced promotional and advertising expenses by 48.8% year-on-year, and logistics costs decreased by 27.9%[66] - The company’s interest expenses on borrowings decreased to RMB 8,926,000 in 2023 from RMB 14,743,000 in 2022, reflecting a reduction of approximately 39.1%[27] Assets and Liabilities - The total assets as of December 31, 2023, were RMB 1,157.4 million, down from RMB 1,765.6 million as of December 31, 2022[8] - The company reported a total liability of RMB 1,157,351,000 as of December 31, 2023, compared to RMB 1,002,436,000 in 2022, an increase of approximately 15%[11] - The company’s total equity amounted to RMB 727,258,000 as of December 31, 2023, compared to RMB 763,133,000 in 2022, a decline of approximately 5%[11] - The debt-to-asset ratio as of December 31, 2023, was 37.2%, a decrease of 19.6 percentage points from 56.8% as of December 31, 2022[4] - The total borrowings decreased to RMB 222,976 thousand in 2023 from RMB 435,238 thousand in 2022, reflecting the company's strategy to reduce debt levels[44] Inventory and Receivables - As of December 31, 2023, inventory was RMB 279.6 million, a decrease of 47.8% from RMB 535.7 million as of December 31, 2022[4] - The company had a total of RMB 243,697,000 in trade and other receivables as of December 31, 2023, down from RMB 492,647,000 in 2022, indicating a reduction of approximately 50.5%[41] - The trade receivables aged analysis showed a total of RMB 186,633 thousand as of December 31, 2023, down from RMB 303,225 thousand in 2022, indicating a significant reduction in receivables[42] Future Outlook and Strategy - The company anticipates a challenging external environment in 2024, focusing on expanding sales channels and providing diverse consumer experiences[86] - The company aims to optimize its product structure and increase the sales proportion of high-margin products to improve overall profitability[61] - The company has committed to investing in health food and skincare products through brand co-creation and incubation strategies[88] Corporate Governance and Shareholder Matters - The company maintains high standards of corporate governance to protect shareholder interests and enhance corporate value[92] - The board does not recommend the payment of a final dividend for the year ending December 31, 2023 (2022: none) [97] - The audit committee has reviewed the group's audited consolidated annual performance for the year ending December 31, 2023 [99] - The independent auditor has confirmed the consistency of the financial figures in the preliminary announcement with the audited consolidated financial statements for the year ending December 31, 2023 [100]